Literature DB >> 6441669

Oral gold (auranofin) in juvenile rheumatoid arthritis: a 48-week phase II study.

T K Kvien, H M Høyeraal, B Sandstad, E Kåss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6441669     DOI： 10.1007/bf02031282

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  4 in total

1.  Assessment methods of disease activity in juvenile rheumatoid arthritis--evaluated in a prednisolone/placebo double-blind study.

Authors:  T K Kvien; H M Høyeraal; B Sandstad
Journal:  J Rheumatol       Date:  1982 Sep-Oct       Impact factor: 4.666

2.  Gold levels produced by treatment with auranofin and sodium aurothiomalate.

Authors:  D Lewis; H A Capell; C J McNeil; M S Iqbal; D H Brown; W E Smith
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

3.  Diagnostic criteria of rheumatoid arthritis in children. Proposed criteria for controlled clinical studies.

Authors:  T K Kvien; H M Høyeraal; E Kåss
Journal:  Scand J Rheumatol       Date:  1982       Impact factor: 3.641

4.  Auranofin in the treatment of juvenile rheumatoid arthritis.

Authors:  E H Giannini; E J Brewer; D A Person
Journal:  J Pediatr       Date:  1983-01       Impact factor: 4.406
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.